Daniel Bradbury - 14 Feb 2025 Form 4 Insider Report for Equillium, Inc. (EQ)

Reporting relationship: EXECUTIVE CHAIRMAN, Director, 10%+ Owner
Issuer ticker: EQ
Reported as of: 14 Feb 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 19 Feb 2025, 19:42:33 UTC
Prior SEC filing: 07 Feb 2025
Next SEC filing: 23 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Jason A. Keyes, Attorney-in-Fact

Key filing fact

Daniel Bradbury filed Form 4 for Equillium, Inc. (EQ) on 19 Feb 2025.

Key facts

This page summarizes Daniel Bradbury's Form 4 filing for Equillium, Inc. (EQ).
12 reported transactions and 12 derivative rows are listed below.
Accepted by SEC: 19 Feb 2025, 19:42.

Change

Previous filing in this sequence was filed on 07 Feb 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

EQ transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +90,000
Change %
Price
Shares after: 90,000
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 90,000
Exercise price: $0.7850
Footnotes: F1, F2

EQ transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -90,000
Change %: -100%
Price
Shares after: 0
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 90,000
Exercise price: $7.16
Footnotes: F1, F2

EQ transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +36,000
Change %
Price
Shares after: 36,000
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 36,000
Exercise price: $0.7850
Footnotes: F1, F2

EQ transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -36,000
Change %: -100%
Price
Shares after: 0
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 36,000
Exercise price: $4.75
Footnotes: F1, F2

EQ transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +28,708
Change %
Price
Shares after: 28,708
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 28,708
Exercise price: $0.7850
Footnotes: F2, F3

EQ transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -28,708
Change %: -100%
Price
Shares after: 0
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 28,708
Exercise price: $3.53
Footnotes: F2, F3

EQ transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +36,000
Change %
Price
Shares after: 36,000
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 36,000
Exercise price: $0.7850
Footnotes: F1, F2

EQ transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -36,000
Change %: -100%
Price
Shares after: 0
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 36,000
Exercise price: $5.03
Footnotes: F1, F2

EQ transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +38,000
Change %
Price
Shares after: 38,000
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 38,000
Exercise price: $0.7850
Footnotes: F1, F2

EQ transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -38,000
Change %: -100%
Price
Shares after: 0
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 38,000
Exercise price: $3.59
Footnotes: F1, F2

EQ transaction Derivative

Employee Stock Option (right to buy)

Award

Transaction value
Shares: +50,000
Change %
Price
Shares after: 50,000
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $0.7850
Footnotes: F1, F2

EQ transaction Derivative

Employee Stock Option (right to buy)

Disposed to Issuer

Transaction value
Shares: -50,000
Change %: -100%
Price
Shares after: 0
Date: 14 Feb 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 50,000
Exercise price: $1.06
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Twenty-five percent of the shares subject to the option vests on the first anniversary of the vesting commencement date, and the remainder vests in 36 equal monthly installments thereafter for the following three years.

Footnote F2

On August 7, 2023, the Board of Directors of the Company approved the repricing of certain options based on the closing price of the Company's common stock on August 14, 2023. The repricing of these options was subject to a holding period that lapsed on February 14, 2025. The repricing resulted in the impacted options having a lower exercise price of $0.785 per share, which is the closing price of the Company's common stock on the Nasdaq Capital Market on August 14, 2023. All of the other terms of the options remained unchanged.

Footnote F3

The shares subject to this option became fully vested on the grant date of May 28, 2020.